Table 3 Patients charactreristics in leucine enriched and standard BCAA dietary supplements
Case | GCS on admission | Diagnosis | Medical history | BMI | BW | Cre on admission | eGFR on admission | T-CHO on admission | TG on admission | mRS before stroke | EN (1 pack) | Protein intake by EN (g/day) | Protein intake by EN (g/kg/day) | Calorie intake (/day) | Target calorie (/day) | Outcome | Hospitalization (days) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leucine enriched BCAA dietary supplement | |||||||||||||||||
1 | 7 | Cardioembolic stroke | Af, HT, Asthma | 23.3 | 62 | 0.73 | 58.15 | 201 | 94 | 0 | Impact (250 k, P14g) | 70 | 1.1 | 1250 | 1515 | Discharge | 8 |
2 | 13 | Ischemic stroke (Large vessel occlusion) | HT, DM, ASO, post-surgery of rectal cancer | 24.5 | 65 | 0.78 | 74.03 | 241 | 203 | 0 | Peptamen AF (300 k, P19g) | 75.6 | 1.2 | 1200 | 1434 | Discharge | 15 |
3 | 15 | Intracerebral hemorrhage (hypertensive) | HT, CRF (HD), hypothroidism | 18.4 | 50 | 6.96 | 6.56 | 97 | 58 | 3 | Renalen MP (400 k, P14g) | 42 | 0.8 | 1200 | 1239 | Discharge | 11 |
4 | 9 | Intracerebral hemorrhage (hypertensive) | HT, ASO | 21.8 | 49 | 1.04 | 52.47 | 174 | 56 | 3 | Peptamen AF (300 k, P19g) | 75.6 | 1.5 | 1200 | 1122 | Discharge | 14 |
5 | 11 | Cardioembolic stroke | HT, DM, CKD, Anemia | 18.3 | 44 | 1.75 | 21.30 | 206 | 101 | 5 | Renalen MP (400 k/P) | 42 | 1.0 | 1200 | 1328 | Discharge | 12 |
6 | 12 | Cardioembolic stroke | Af, HT, DM, MVR | 17.6 | 45 | 0.74 | 57.51 | 139 | 42 | 0 | Peptamen AF (300 k, P19g) | 75.6 | 1.7 | 1200 | 1344 | Discharge | 8 |
7 | 7 | Intracerebral hemorrhage (hypertensive) | HT, DL, CKD | 13.9 | 30 | 0.71 | 56.44 | 286 | 65 | 3 | MEIN (200 k, P10g) | 60 | 2.0 | 1200 | 1005 | Discharge | 12 |
8 | 3 | Intracerebral hemorrhage (hypertensive) | Paf, HT, DM, Dementia, DVT | 23.5 | 64 | 0.68 | 80.80 | 159 | 87 | 2 | MEIN (200 k, P10g) | 70 | 1.1 | 1400 | 1803 | In-hospital death | 8 |
9 | 9 | Ischemic stroke (Large vessel occlusion) | HT, DL, CKD, CHF | 20.6 | 44 | 0.86 | 45.76 | 256 | 124 | 5 | MEIN (200 k, P10g) | 60 | 1.4 | 1200 | 1081 | Discharge | 14 |
10 | 5 | Intracerebral hemorrhage (hypertensive) | HT, DL, ASO, OMI (post-CABG), post-CAS | 23.4 | 58 | 0.92 | 50.61 | 137 | 167 | 0 | MEIN (200 k, P10g) | 70 | 1.2 | 1400 | 1356 | Discharge | 10 |
11 | 14 | Ischemic stroke (Large vessel occlusion) | Af, HT, DM, DL, CRF, post-CABG, stent gradt for AAA | 22.3 | 57 | 9.35 | 4.75 | 119 | 92 | 3 | MEIN (200 k, P10g) | 70 | 1.2 | 1400 | 1521 | Discharge | 17 |
12 | 15 | Cardioembolic stroke | Af, HT, left IC occlusion, breast cancer | 25.7 | 57 | 0.59 | 71.84 | 216 | 65 | 0 | MEIN (200 k, P10g) | 70 | 1.2 | 1400 | 1563 | Discharge | 13 |
13 | 7 | Cardioembolic stroke | Af, HT, DL, IGT, Lung cancer, DVT, intracerebral aneurysm (unruptured) | 23.5 | 55 | 0.76 | 56.39 | 158 | 102 | 0 | Renalen MP (400 k, P14g) | 42 | 0.8 | 1200 | 1293 | In-hospital death | 21 |
14 | 14 | Cardioembolic stroke | Paf | 15.8 | 37 | 0.70 | 59.18 | 188 | 128 | 3 | Peptamen AF (300 k, P19g) | 75.6 | 2.0 | 1200 | 1063 | Discharge | 16 |
15 | 8 | Cardioembolic stroke | HT, right MCA stenosis | 17.3 | 39 | 0.83 | 47.72 | 210 | 58 | 4 | MEIN (200 k, P10g) | 50 | 1.3 | 1000 | 943 | Discharge | 8 |
Median | 9 | 21.8 | 50 | 0.78 | 56.4 | 188 | 92 | 3 | 70 | 1.2 | 1200 | 1328 | 12 | ||||
Standard BCAA dietary supplement | |||||||||||||||||
1 | 7 | Ischemic stroke (Large vessel occlusion) | HT, DL, Paf | 22.6 | 67 | 0.77 | 71.7 | 206 | 36 | 0 | Impact (250 k, P14g) | 70 | 1.0 | 1500 | 1628 | Discharge | 10 |
2 | 13 | Cardioembolic stroke | Af, HT, DM, Obesity, OCI | 25.8 | 62 | 0.49 | 92.8 | 161 | 63 | 0 | Peptamen AF (300 k, P19g) | 75.6 | 1.2 | 1200 | 1321 | Discharge | 11 |
3 | 14 | Cardioembolic stroke | DM, OCI, AAA | 16.5 | 45 | 0.65 | 91.1 | 159 | 105 | 2 | Peptamen AF (300 k, P19g) | 94.5 | 2.1 | 1500 | 1350 | Discharge | 14 |
4 | 3 | Cardioembolic stroke | HT, DM, HL, CABG,OCI, Basedow, | 19.5 | 44 | 1.15 | 35.2 | 133 | 90 | 4 | MEIN (200 k, P10g) | 60 | 1.4 | 1200 | 1077 | Discharge | 8 |
5 | 4 | Cardioembolic stroke | Paf, HT, HL, DM | 23.8 | 50 | 0.9 | 44.4 | 235 | 116 | 2 | Impact (250 k, P14g) | 56 | 1.1 | 1000 | 1036 | Discharge | 9 |
6 | 13 | Ischemic stroke (small vessel occlusion) | HT, AP, OCI, Dementia, DVT | 22.0 | 55 | 0.68 | 60.9 | 241 | 85 | 4 | MEIN (200 k, P10g) | 60 | 1.1 | 1200 | 1286 | Discharge | 10 |
7 | 12 | Intracerebral hemorrhage (hypertensive) | HT, DVT | 20.0 | 45 | 0.71 | 58.1 | 205 | 133 | 3 | MEIN (200 k, P10g) | 50 | 1.1 | 1000 | 1258 | Discharge | 10 |
8 | 8 | Cardioembolic stroke | Af, HT, OCI, DL | 24.0 | 54 | 0.47 | 92.4 | 206 | 113 | 4 | Peptamen AF (300 k, P19g) | 75.6 | 1.4 | 1200 | 1340 | Discharge | 9 |
9 | 11 | Intracerebral hemorrhage (hypertensive) | HT | 14.5 | 39 | 0.48 | 91.7 | 182 | 34 | 0 | Impact (250 k, P14g) | 56 | 1.4 | 1000 | 1054 | Discharge | 9 |
10 | 8 | Ischemic stroke (Large vessel occlusion) | HT, DM, DL | 21.8 | 63 | 0.6 | 97.5 | 223 | 98 | 4 | Peptamen AF (300 k, P19g) | 94.5 | 1.5 | 1500 | 1590 | Discharge | 18 |
11 | 3 | Cardioembolic stroke | Paf, HT,LC | 15.9 | 43 | 1.68 | 30.8 | 126 | 1 | Renalen MP (400 k, P14g) | 35 | 0.8 | 1000 | 1111 | In-hospital death | 10 | |
12 | 9 | Ischemic stroke (Large vessel occlusion) | HT,DM,OCI, DL, Dydrocephalus, ASO | 18.7 | 42 | 0.72 | 56.8 | 189 | 171 | 5 | Peptamen AF (300 k, P19g) | 75.6 | 1.8 | 1200 | 1238 | Discharge | 7 |
13 | 10 | Ischemic stroke (small vessel occlusion) | HT, SAH | 15.0 | 36 | 0.52 | 83.7 | 163 | 96 | 4 | Peptamen AF (300 k, P19g) | 75.6 | 2.1 | 1200 | 1099 | Discharge | 7 |
14 | 13 | Cardioembolic stroke | HT, HL, DM | 18.1 | 48 | 0.92 | 60.6 | 159 | 75 | 0 | Peptamen AF (300 k, P19g) | 75.6 | 1.6 | 1200 | 1218 | Discharge | 22 |
Median | 9.5 | 19.7 | 46.5 | 0.70 | 66.3 | 186 | 96 | 3 | 72.8 | 1.4 | 1200 | 1248 | 10 | ||||